The American Heart Association Scientific Sessions OnDemand 2025 is a premier cardiovascular conference showcasing the latest scientific discoveries, late-breaking clinical trials, and innovative therapeutic strategies. The program covers a broad spectrum of topics, including heart failure, structural heart disease, preventive cardiology, and the integration of artificial intelligence in cardiovascular medicine.

Course Date: 2025

2. Learning Objectives

• Evaluate late-breaking clinical trials and their implications for contemporary cardiovascular care.

• Implement updated American Heart Association guidelines for managing heart failure, arrhythmias, and ischemic heart disease.

• Assess the integration of artificial intelligence, digital health, and novel technologies in cardiovascular diagnosis.

• Analyze emerging pharmacological therapies and interventional strategies for complex structural heart diseases.

• Develop strategies to address health equity and social determinants of health in cardiovascular practice.

3. Target Audience

Best for cardiologists and researchers who want updates on late-breaking clinical trials, AHA guidelines, and digital health innovations.

4. Topics

• 2025 AHA Blood Pressure Guideline & CKD Management_ Key Insights and Global Perspectives

• 2025-2035_ Questions to be Addressed in Heart Failure Research in the Next 10 Years

• 3CPR Speed Mentoring

• A Vision for the Future of Clinical Registries in Pediatric Cardiovascular Care

• A Window of Opportunity_ Leveraging Non-cardiac Imaging to Guide CVD Risk Assessment

• Access to Heart Failure Care in Women and Under-Represented Populations_ Challenges and Solutions in the U.S. and Worldwide

• Adapting to Change_ Navigating the Evolving Landscape of Research Funding

• Adding Years to Life and Life to Years

• Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction

• Advances in Global Health Research_ Opportunities and Challenges

• Advances in Pacing and ICDs

• Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis

• Advancing Cardiovascular Care in Older Adults_ Pragmatic Trials and Hypertension Management

• AF Lifestyle Therapy_ Drugs Beyond Heart Failure and Obesity

• Age-Specific Molecular Mechanisms of Disease in the Young

• AHA_JCS Joint Session

• AI in Action_ A Hands-on Workshop on LLM- Powered Quality Assessment and Improvement in the EHR

• AI-Powered Life Saving_ Revolutionizing Resuscitation Science

• Aldosterone and Mineralocorticoid Receptors_ New Paradigms and Novel Therapies A Hypertension_AHA Journals Session

• An Introduction to Clinical Cardiovascular Genetic Testing Best Practices_ A Flipped Classroom-Style Session

• Ancel Keys Memorial Lecture

• Ancestry, Sex, and Vulnerable Populations in the Implementation of Cardiovascular Genomic Medicine

• Annual Dr. Nanette K. Wenger Research Goes Red Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women

• Annual Lipid Update 2025

• Applying Cardiovascular Genomics in the Clinic and Beyond

• Approach to Genetic Cardiac Diseases_ Coloring Outside the Lines

• Approaches to Ischemic Heart Disease Before During and After Hospitalization

• Approved and Novel Therapies for the Management of Obstructive and Nonobstructive HCM

• Are Cardiovascular Theragnostics Ready for Prime Time or Just a Pipe Dream

• Arteries and Veins in Trouble_ VTE and PAD

• Assessment of the Coronary Microcirculation_ Do Children Need Invasive Assessment of Coronary Microvascular Function_

• At the Heart of the Matter_ Navigating Aortic Valve Decisions for a Lifetime

• Bad Blood_ Swift(ie) Debates in Cardio-Oncology

• Basics to Hot Topics in Valves and TAVR imaging

• Basic_Translation Abstract Oral Session

• Beating the Unexpected_ Predicting and Preventing Sudden Cardiac Death in Young Persons

• Best of the Best Abstract Oral Session

• Best Practices for Obesity, Diabetes, and Chronic Kidney Disease Management

• Beyond the Usual Suspects_ Atypical Causes of Shock in the CICU

• Big Data Buffet_ Leveraging Big Data Approaches to Improve Health

• Biological and Pragmatic Interventions in Heart Failure_ From Present to Future

• Brain, Heart, and Risk_ Advancing Cognitive and Cardiovascular Protection

• Breaking the Bad_ How Vascular Practitioners Can Optimize Antithrombotic Therapy

• Bridging the Gap Leveraging Innovation to Address Unmet Needs in Cardiovascular Care (AHA Joint Session with the Association of Black Card

• Bringing to Life the HEARTS Act

• Building a Career That Maximizes Impact on All Populations

• Building a Super Fontan

• Building and Running an Efficient EP Laboratory

• Building Bridges_ Strategies to Overcome Barriers to Vascular Care Delivery

• Calcium Regulation and Adrenergic Signaling

• Cardiac Arrhythmias in the Structurally Normal Heart_ The Emerging Role of Autoimmune Cardiac Channelopathies

• Cardiogenic Shock_ What Can Adult and Pediatric Clinicians Learn from Each Other_

• Cardiometabolic and Lifestyle Interventions for AF

• Cardiometabolic Interventions for the Vulnerable Plaque and Vulnerable Patient

• Cardiovascular Aging and Revascularization in Older Adults_ When to Stent, When to Bypass, and When to Step Back

• Cardiovascular Disease Prevention Extends Beyond the Heart

• Cardiovascular Health in Women_ Unique Vulnerabilities in Women and Implications for Therapeutics – An ATVB_AHA Journals Session

• Cardiovascular Precision Therapy is at the Bedside

• Career Horizons_ Preparing for the Journey Beyond Fellowship

• Cell Fate Mechanisms in Cardiac Development and Disease

• Changing Landscape in Lymphatic and Cardiovascular Disease_ From Population Science to Molecular Mechanisms

• Changing Our Approach to Severe Hypertension

• Charles T. Dotter Memorial Lecture

• Circulating Global Health Knowledge_ Key Findings from AHA Journals

• Circulation_ Innovation in Cardiovascular Science and Medicine_ An AHA Journals Session

• CKM Screening, Staging, Social Drivers of Health, and Risk Prediction

• Clinical Abstract Oral Session

• Clinical Conundrums in Cardio-Oncology_ Advancing Care Through Interdisciplinary Collaboration

• Collaboration in Cardiovascular Research_ Advancing Science and Improving Outcomes

• Competitive Sports Participation for Athletes with Heart Disease_ New Guidance and Future Directions

• Complications of Hypertrophic Cardiomyopathy_ Recognition and Treatment of Arrhythmias and Advanced Heart Failure

• Confronting the Global Burden of Hypertension

• Contemporary Controversies in Cardiac Transplantation and Circulatory Support Devices

• Contemporary Conundrums in the CICU – When Experts Disagree! Get the International Perspective

• Contemporary Management of Venous Disease_ The New, The Old, and The Evolving

• Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years_ TAVR vs SAVR First Strategy

• Controversies in Primary Prevention (Debates)_ Heart and Brain Health

• Cournand and Comroe Early Career Investigator Award Competition

• Cracking the Code_ Turning the 2025 ACC_AHA High Blood Pressure Guideline Into Actionable Practice

• Cutting Edge Techniques to Optimize Cardiac Surgery Outcomes

• Cutting Edge Valve and Coronary Trials

• CVSA Early Career and Vivien Thomas Early Career Investigator Award Competitions

• Data Organization and Management in the Data Sharing and Omics Era

• Debates_ What will be the Best EP Practices for the Future_

• Deciphering Vascular and Lymphatic Pathology in the Space of Atherosclerotic and Coronary Heart Disease

• Declining Cardiovascular Nursing Workforce_ Strategies for Improvement

• Decoding Cardiomyopathy and Myocarditis_ Insights from Single-Cell Transcriptomics

• Defining Success in EP Clinical Trials

• Deregulation of Ion Channels in Heart Rhythm Abnormalities

• Developing Your Career in Pediatric Cardiology

• Diabetes, CKD and CVD Risk_ From Mechanisms to Management

• Dickinson W. Richards Memorial Lecture

• Digital Twins in Cardiac Electrophysiology_ Hype, Hope, or a Bit of Both_

• Dilemmas in Antithrombotic Therapy in AF Care Post Procedures

• Distinguished Scientist Lecture Session

• Don’t Risk It_ AF Related Stroke Prevention

• Drugs and Hypertension New Treatments Causing Hypertension and New Mechanisms for Treatment

• Early Career Investigator Showcase_ Spotlight on AHA Funded Research – Basic Science

• Early Career Investigator Showcase_ Spotlight on AHA Funded Research – Clinical & Population Science

• Early Career, Big Impact_ Building Your Future with AHA (Early Career Day Opening Session)

• Early Clinical Trials on Heart Repair

• EHJ and Circulation_ Advances in 2025

• Elevating Your Career_ Maximizing AHA’s Opportunities for Writing, Engaging, and Growing for Fellows-in-Training and Early Career Members

• Elizabeth Barrett-Connor Research Award for Early Career Investigators in Training Competition

• Engineering Heart, Vessels, and Valves

• Everything You’ve Wanted To Ask a Nephrologist About Managing Hypertension but Were Too Afraid To!

• Extracellular Matrix Dynamics in Vascular Health and Disease

• Featured Science in EP

• Featured Science_ Hypertrophic Cardiomyopathy Medical Society

• Fibrosis_ Healing Hearts without Damaging Them

• Finding Common Ground_ Controversies in PAD and CLTI Management

• Forgotten No More_ The Current Belle of the Ball_ Breakthrough Evolutions in Hypertrophic Cardiomyopathy

• Frenemies_ Leadless and Physiologic Pacing

• From Arch to Pelvis_ The Latest Advances in Aortic Treatments and Team Based Care Models

• From Drugs to Diet_Lifestyle_ Practical Tips for Cardiovascular Risk Conversations in Clinical Care

• From End of Fellowship to Mid-Career_ Cardio-Oncology as a Paradigm

• From Genes to Treatment_ Advancing Aortic Aneurysm Therapies Through Genomic Insights

• From Madrid to Mardi Gras_ Heart Failure Trials on Parade

• From Molecules to Mechanics_ Top Translational Advances in Valvular Heart Disease

• From Molecules to Models_ Redefining Cardiovascular Care Across Systems and Syndromes

• From SCAD to Microvascular Dysfunction and Beyond – Changing Paradigms of IHD in Women

• Funding Opportunities

• Gene Therapy_ Repair the Heart by Targeting its Genes

• Generative AI to Build a New Future of Cardiovascular Care

• Genetic Insights and Precision Approaches in Congenital Heart Disease_ Early Risk Prediction and Therapeutic Strategies

• Genomic and Epidemiology Mid-Career Research Award and Lecture

• Genomic and Precision Medicine Early Career Investigator Award Competition

• Genomic and Precision Medicine Symposium Model systems Preclinical to Phase I Bridge Session 1, Model Systems and their Application

• Genomic and Precision Medicine Symposium_ Model Systems_ Preclinical to Phase I Bridge_ Session 2, Assessing Therapeutics in Model Systems

• Genomic and Precision Medicine Symposium_ Model Systems_ Preclinical to Phase I Bridge_ Session 3, The Evolving Landscape of Regulation

• George E. Brown Memorial Lecture

• George Lyman Duff Memorial Lecture

• Geriatrics_ Practical Issues in Hypertensive Care

• Getting it Right_ Understanding and Treating Right Ventricular Dysfunction

• Getting to the Grant

• Getting to the Heart of Metabolic Health An Update on Cardiovascular Kidney Metabolic Syndrome (Joint Session with the European Society

• Getting to the Heart of the One Big Beautiful Bill_ How Sweeping Reforms Will Reshape Cardiovascular Care

• Global Convergence in Cardiovascular-Kidney-Metabolic Health_ Collaborative Innovation for the Next Era of Care

• Global Innovations in Cardiovascular Prevention and Nursing Leadership

• Goal Directed CPR Whats the Target

• Groundbreaking Trials in Cardiometabolic Therapeutics

• Guidelines to Global Action_ Implementing Hypertension, ACS, and CPR Guidelines Worldwide

• GW-ICC at AHA2025_ Frontiers in Cardiovascular Care (AHA Joint Session with Great Wall International Congress of Cardiology)

• Harnessing Implementation Science for Heart Health Impact

• Harnessing Transcriptomics and RNA-Based Therapies for Cardiovascular Disease

• Heart Failur-omics_ Understanding as Many as Possible Aspects of the Most Lethal Disease

• Heart Failure Horizons_ Collaborative Global Strategies to Shift the Prevention Paradigm

• Heart Failure Management Across Kidney Stages_ From CKD to ESRD and Transplant

• Heart Failure Wars_ Gene Therapy Strikes Back_ An AHA Journals Session

• Heart in the Epicenter of Interorgan Networks

• Heart of the Matter_ Novel Mechanisms and Treatment of CVD in CKD

• Heart Repair With or Without Cardiomyocytes

• Heart Restart & Going Beyond the Pulse_ Unveiling the 2025 Cardiac Arrest Guidelines

• Henning Lecture_ Preventing Cardiometabolic Disease in Youth and Compressing CMD with Ageing

• HFpEF and CKM Syndrome_ Overlap, Interplay and Opportunities to Optimize Outcomes

• HFpEF in 2025_ Trials and Triumphs

• Highlights in Aortic Disease_ What Everyone Needs to Know

• Hospital at Home_ Model of the Future for Acute Heart Failure Care_

• Hottest Clinical Trials in Valvular Heart Disease_ Key Insights from Late-Breaking Studies

• How Can Innovative Approaches to Pediatric and Congenital Heart Disease Globally Make Me a Better Cardiologist

• How Fetal Care Informs and Directs Comprehensive Care of Patients with Congenital Heart Disease

• How I Built This_ Unique Clinical Programs to Improve CHD Care

• Hypertension From Childhood to Adolescence to Young Adulthood_ How Do We Best Treat our Patients Without Hard Trial Evidence_

• Hypertrophic Cardiomyopathy Across the Lifespan_ Risk Stratification, Diagnosis, and Management

• Hypertrophic Cardiomyopathy Medical Society Oral Abstracts

• I Ordered Genetic Testing_ Now What_

• Imaging Conundrums at the Intersection of Pediatrics and Adult

• Imaging for Precision and Outcomes in Structural Heart Disease Procedures_ An AHA Journals Session

• Impact of Caregiver Burden on Cardiovascular and Brain Health

• Impact of Genetics on the Family from Mendelian to Polygenic

• Implementation Science for Impact_ Behavioral Interventions in Community Settings

• Implementing Protocolized Patient Care Structures_ Instead of Relying on Everyone Being Above Average – An Innovation Session

• Inflammation and Atherosclerosis_ Smoldering Threat or Therapeutic Target_

• Inflammation in Preclinical vs. Clinical PAH A Provocative Debate

• Inflammation, Pollution, Microplastics and CAD

• Inflammatory Mediators of Inter-organ Cross-talk during Cardiovascular Disease

• Influenza and COVID Science

• Innovation at the Bench to Prime-Time Therapies at the Bedside

• Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH

• Innovations in mHealth_ Lessons from NIH Sponsored Trials

• Innovations in Pediatric Cardiovascular Science_ Pioneering Pathways for the Future

• Innovations in Valvular Heart Disease Talks from Basic Science to Clinical Trials to Breakthrough Innovations in Surgical and Transcathete

• Innovative Therapeutic Strategies in Cardiovascular Health_ Translating Research into Practice

• Instrument Thunderdome_ Measuring Caregiver Burden in Cardiovascular Disease and Stroke

• Integrative and Whole-Person Approaches to Vascular Health_ Bridging Science, Systems, and Practice – A JAHA_AHA Journals Session

• Interactive Cases in Structural Heart Disease

• Interdisciplinary Care and Cardiovascular Kidney Metabolic Coordinators

• Is QI Dead_ Long Live Health Systems 2.0

• Jay D. Coffman Early Career Investigator Award Competition

• Katharine Lembright Award and Lecture and the Martha N. Hill New Investigator Award Competition

• Keep it Simple_ Cutting Edge Vascular, Lipid, and Coagulation Research

• Kenneth Bloch Memorial Lecture in Vascular Biology

• Laennec Clinician-Educator Award & Lecture

• Laennec Fellow In Training (FIT) Clinician Award Competition

• Laissez Les Bons Temps Rouler_ Resilience in the Face of Adversity

• Late-Breaking Resuscitation Science Abstracts

• LBS In Depth – CRISPR-Cas9 Gene Editing Therapy Targeting ANGPTL3

• LBS In Depth – The VESALIUS-CV Trial

• Lessons from an NIH Career_ Both_And Thinking to Navigate an Uncertain Future

• Lessons from the Masters_ My Worst Day in the EP Lab

• Lessons Learned_ School Health is Cardiovascular Health

• Leveraging Artificial Intelligence in Cardiac Imaging

• Lifelong Care in Women_ A Circulation Research_AHA Journals Session

• Lightning Round_ Challenging Pediatric and Adult Critical Care Practices

• Lipid Lowering Therapies and Lipid Risk Factors

• Lipid Therapies_ Translation to Implementation

• Louis N. and Arnold M. Katz Basic Science Research Prize for Early Career Investigators Competition

• Making the Heart Regenerative Again

• Managing Arrhythmias and Cardiac Implantable Devices in Advanced Heart Failure and Heart Transplant Recipients

• Managing Arrhythmias in Special Populations

• Managing Double Trouble, How the Experts Approach Complex Cases

• Mastering Aortic Stenosis_ Get with the Guidelines for Cardiology & Primary Care

• Mechanisms Underlying Vascular Dysfunction

• Melvin Judkins Early Career Clinical Investigator Award Competition

• Melvin L. Marcus Early Career Investigator Award in Cardiovascular Sciences Competition

• Metabolic Dysregulation in PAH – From Lipids to Amino Acids

• Metabolic Stress, Mitochondrial Injury, and Inflammatory Drivers in Cardiac Pathophysiology

• Microaggressions_ How You Can Create Cultural Change at Your Institution to Eliminate Them

• Mitochondrial Function in Cardiovascular Disease

• Mitral and Tricuspid Regurgitation_ Everything You Need to Know to Properly Image and Treat with TEER

• MolCel_ Endocrine Mechanisms that Regulate Cardiometabolic Health

• MolCel_ Endothelial Regulation of Cardiac and Systemic Metabolism as Mediators of Heart Disease

• MolCel_ Heart Failure_ A State of Metabolic Imbalance

• Molecular and Functional Insights in Cardiovascular Aging

• Molecular Insights in HFpEF Pathophysiology

• Molecular Mechanisms of Cardiac Development

• Move Over Lungs and Right Heart! Systemic Organ Dysfunction in PAH

• Moving the Needle_ Valve Disease in the Young and Moderate Risk

• Multi-Omic Modifiers of Cardiovascular Health

• Multimodality Imaging for Diagnosis, Risk Stratification and Management of Hypertrophic Cardiomyopathy

• Multimorbidity_ Hypertension, Hyperlipidemia and Cardiovascular Disease

• My Patient Has Pulmonary Hypertension on an Echocardiogram_ What Do I Do_

• Navigating AHA Scientific Statements_ Advancing Evidence-Based Cardiovascular Care

• Neural Regulation of Cardiac Function

• New Frontiers in the Management of Cardiac Dysautonomias

• New Insights and Treatment Options in Diabetes Associated Cardiometabolic Disease

• New Onset HFpEF and LVH – Don’t Miss the Treatable Zebra_ How to Diagnose and Treat Cardiac Amyloidosis in 2025

• New Technologies for Managing Ventricular Arrhythmias and Sudden Cardiac Death

• Next-Gen Research_ Harnessing AI Across Trials, Sensors, and Digital Interfaces

• Next-Generation Therapies for Ischemic Heart Repair_ From Cells to Imaging

• Nobel Laureate Address

• Nourishing Tiny Hearts_ Advancing Human Milk Science and Practice for Children with Congenital Heart Disease

• Novel Imaging Techniques and Applications in the Management of Cardiomyopathies

• Novel Insights in CKM Prevalence and Risk Prediction

• Novel Insights into Cardio-oncology

• Novel Molecular Pathways in Cardiac Health and Disease_ From Stress Responses to Regeneration

• Novel Molecular Targets for Heart Repair

• Obesity_ Refining Definitions and Clinical Approaches

• One Ventricle, Many Challenges_ Navigating Non-Cardiac Surgery in Single Ventricle Patients

• Optimizing Brain Health_ Enhancing Operations and Patient Experience with AI

• Optimizing CKM Health in Primary Care

• Optimizing Preventative Care_ Core Competencies for Clinical Cardiologists

• Paul Dudley White International Lecture and Session

• Pecha Kucha Says_ It’s All About Managing Cardiovascular-Kidney-Metabolic Health

• Periprocedural Atrial Fibrillation_ From Molecular Insights into Therapeutic Strategies

• Personalized, Potent, and Precise_ The Evolving Drug Landscape in AMI

• Pioneering Progress in Maternal Heart Health_ Research, Risk, and Response Across Borders

• Plaque Imaging_ Finding the Best Metrics and Algorithms

• POTS and PANS_ What’s Cookin with Orthostatic Intolerance

• Practical Strategies for Managing Hypertension and CKD in HFpEF

• Practice Changing Trials in Blood Pressure Control

• Pragmatic Clinical Trials in the Electronic Health Record

• Pregnancy and CKM Health_ What Does the Cardiologist Need To Know_

• Pregnancy-related Hypertensive Disorders and Brain Health

• Presidential Session & Conner Lecture

• Primary Mitral Regurgitation_ Current State and Future Innovations

• Private Equity and Cardiovascular Care Delivery

• Protecting Your First Steps & Obtaining Funding in an Evolving Landscape Words of Wisdom from Academic Leaders

• Publishing Your Work_ A Discussion with Leading Journal Editors

• Pumped Up_ Unveiling the opportunities of ECPR

• QCOR Early Career Investigator Abstract Award Competition

• Quest Diagnostics Early Career Investigator Award for Preventive Cardiovascular Medicine Research Competition

• Raising Lazarus–Raising Cardiogenic Shock Patients from the Dead

• Real-World Implementation of AI in Pediatric Cardiology

• Recent Advances in PAH

• Recipes for Success in Heart Failure

• Refining Therapeutic Approaches for CKM Syndrome

• Remote BP Monitoring and Drug Titration Does it work How do we do it

• Resuscitation Guidelines Session_ Pioneering and_or Presumptuous_!

• Rewriting the Code for Cardiac Amyloid_ Novel Identification, Treatment, and Cure

• Rise of Machine Algorithms Across the Globe for Acquired and Congenital Heart Disease

• RNA Homeostasis in Control of the Cardiovascular System

• Robert I. Levy Memorial Lecture and Lifestyle and Cardiometabolic Health Early Career Investigator Award Competition

• Russell Ross Memorial Lectureship in Vascular Biology

• Samuel A. Levine Early Career Clinical Investigator Award Competition

• Sarcomere Biology in Health and Disease

• Saving Brain with Optimal Hypertension Treatment_ Unpacking Critical Connections in Aging Health

• Science-NIH Forum_ Aligning CV Research and Funding Priorities

• Scientific Sessions 2025 Opening Session

• Seeing is Believing_ Novel Imaging Techniques for Arrhythmia Management

• Sensing the Future of Heart Failure and Arrhythmias

• Shifting Paradigms in Lipid Management for ASCVD Risk

• Shock-ing Debates in Cardiac Arrest Resuscitation

• Small Annulus & Severe MAC_ Navigating Complex Valvular Disease in Women

• Small but Mighty_ Platelets in Cardiovascular Diseases

• Smarter Care, Healthier Hearts_ AI’s Role in the Future of Cardiovascular Medicine

• So You Want to do Comparative Clinical Effectiveness Research

• Sol Sherry Distinguished Lecture in Thrombosis

• State of the Art Multimodality Imaging in Cardio-oncology

• State-of-the-Art Coronary Imaging & Hemodynamic Physiology

• Stroke at the Intersection of Cardiac Disease_ A Case-Based Discussion

• Stuck Between a Rock and a Hard Place_ Heart Failure and CKD in Critically Ill Patients

• Success is a Journey_ Pack For Yours

• Symptom Science_ From Monitoring to Interoception Exploring the Path Ahead

• T. Duckett Jones Memorial Lecture

• Tackling Tough Cases_ Practical Tips for Hypertension Management

• Targeting Inflammation in Coronary Atherosclerosis

• Targeting Inflammation to Improve Cardiac Arrest Survival

• TCT at AHA Heart Team in Action Life After Transcatheter Therapies Addressing Residual and Progressive Heart Disease

• TCT at AHA Heart Team in Action Secondary MR Still a Management Conundrum

• TCT at AHA Hemodynamic Support Devices What You Need to Know

• TCT at AHA Hot Topics in PAD Intervention

• TCT at AHA Hot Topics in Pulmonary Embolism

• TCT at AHA_ Aortic Regurgitation_ The New Frontier–Imaging, Interventions, and the Future of Treatment

• TCT at AHA_ Beyond Obstructive Coronary Disease_ Misunderstood and Undertreated

• TCT at AHA_ Coronary Physiology in the Cath Lab and Beyond

• TCT at AHA_ Deep Dive into Intravascular Imaging

• TCT at AHA_ Heart Team in Action_ Arrhythmogenic Mitral Valve Prolapse_ Predicting Risk, Protecting Patients, and Personalizing Treatment

• TCT at AHA_ Heart Team in Action_ Complex Scenarios in Aortic Valve Disease Management

• TCT at AHA_ Heart Team in Action_ Heart Failure and Valvular Heart Disease

• TCT at AHA_ Renal Denervation for Hypertension_ What Comes Next_

• Technological Revolution in Clinical Trials

• The 2025 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults

• The AHA Health Care by Food Initiative is Bearing Fruits_ Early Results from the AHA Food is Medicine Pilot Projects

• The Black Box of Opportunities_ Artificial Intelligence in Cardiovascular Research and Medicine

• The Cardiovascular Data-Scientist_ Skill Development in Artificial Intelligence and Informatics

• The Future of Kidney Care_ Bioartificial Organs, AI, and Breakthrough Therapies

• The Heart of the Matter in AF May Actually be the Brain_

• The Journey from Function to Failure for Pediatric Patients with Congenital Heart Disease

• The Latest in Scientific Statements for Arrhythmia Care and Management 2025

• The Latest Innovations in Cardiac Electrophysiology_ A Case-Based Approach (AHA Joint Session with Heart Rhythm Society)

• The New 2025 Guideline for Acute Coronary Syndromes

• The Shifting Landscape of Pediatric Cardiovascular Care

• The Year in Review_ Influential Science

• Thomas W. Smith Memorial Lecture

• To Denervate or Not to Denervate_ Unlocking the Role of Renal Denervation in Resistant Hypertension

• Top 5 Trending Takeaways in Heart Failure, Cardiomyopathy, and Cardio-Oncology

• Toxic Tides_ Microplastics, the Brain, and Dietary Adaptation

• Transformative Advances in Genome Engineering for Precision Therapy

• Translating Data into Outcomes in Critical Care

• Translational Cardio-Immunology_ Precision Therapies for Heart Failure

• Trauma-Informed Care in Congenital Heart Disease What is It and How Can It Help Prevent Future Mental Health Morbidity

• Trials and Deployments of Artificial Intelligence in Cardiology

• Trials and Tribulations of Conducting Trials in Pediatric Cardiovascular Care_ What Lessons We Can Learn From Adult CV Trialists

• Tricuspid Valve Disease – To Intervene or Not to Intervene, that is the Question

• Triglyceride-Rich Lipoproteins in Cardiovascular and Metabolic Disease

• Uncovering the Roots of Atrial Fibrillation_ Mechanisms, Triggers, and Targeted Therapy AHA Joint Session

• Updates in Diabetes Cardiovascular Outcome Trials

• Valve Science Spotlight_ Top Research in Valve Disease

• Vascular Calcification and Gene-editing Therapy in Peripheral and Cardiovascular Disease

• Vascular Mysteries_ Rare Cases and Diagnostic Challenges

• Viral Controversies in Heart Failure, Cardiomyopathy, and Cardio-Oncology

• VTE, PE, CTEPD, and CTEPH_ Decoding the Alphabet Soup

• Welcome Remarks

• Well-being After Stroke and Heart Attack

• What A Busy Cardiologist Needs to Know About Genetics

• When Atherosclerosis Gets Hard_ A Translational Look at Vascular Calcification from the Bench to the Cath Lab

• When the Heart Fails_ Unraveling the Impact of Cardiogenic Shock on Brain Health

• When the Left Heart Goes Bad_ Pulmonary Hypertension Due to Left Heart Disease

• Why You Should Treat Your Body Like a Temple, Not a Tent_ Insights from Cardiometabolic Imaging

• WIIFM_ Engaging with AHA, What’s In It For Me_

• William W. L. Glenn Lecture

• Winning Hearts and Minds_ Engaging Communities for Vascular Research and Clinical Care

• Women and Underrepresented Populations in Research and Care Delivery

• Women in Cardiovascular Imaging From Patient to Workforce

• Young Hearts Early Career Investigator Award Competition